loader image
Thursday, January 8, 2026
77.6 F
McAllen
- Advertisement -

Kristen Cox Appointed to Texas Medical Board District Two Review Committee

Translate to Spanish or other 102 languages!

Governor Greg Abbott has appointed Kristen Cox to the Texas Medical Board District Two Review Committee for a term set to expire on January 15, 2024. Image Source; LinkedIN for illustration purposes
Governor Greg Abbott has appointed Kristen Cox to the Texas Medical Board District Two Review Committee for a term set to expire on January 15, 2024. Image Source; LinkedIN for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN, Texas — Governor Greg Abbott has appointed Kristen Cox to the Texas Medical Board District Two Review Committee for a term set to expire on January 15, 2024.

Kristen Cox of College Station is president and chief executive officer of Checkpoint Services, Inc., and 12th Man Technology. She served for 12 years as a gubernatorial appointee on the Texas Council for Developmental Disabilities. She was a founding board member of El Paso Children’s Hospital and served on the El Paso Children’s Hospital Foundation board. Previously, she served on the boards of Make-A-Wish of El Paso, National Center for Missing & Exploited Children, Alzheimer’s Association, and Rotary Clubs of College Station and El Paso. Cox received a Bachelor of Science in Engineering from Texas A&M University and a Master of Business Administration from The University of Texas at Dallas.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Wegovy® Pill, First Oral GLP‑1 for Weight Loss, Now Available Nationwide

Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time.

Historic Reset of U.S. Nutrition Policy with New Food Pyramid

Mega Doctor News WASHINGTON, D.C. – U.S. Department of Health and Human Services...

Metabolic Trigger Identified That Shuts Down Key Tumor‑Fighting Gene

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center. 

MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
- Advertisement -
×